Skip to main content

Find Clinical Trials

Home
Conditions
Leukemia, Myeloid

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

91 public trials 17 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus

NCT00133367

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Graft vs Host Disease, +27 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients

NCT01511289

Conditions: Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +14 more
Locations: Local Institution Jakarta, Indonesia

Local Institution Batangas, Philippines

Local Institution Manila, Philippines

Local Institution Busan, South Korea

View all 22 locations

View Trial Details

Completed

A Study Of Panobinostat In Children With Refractory Hematologic Malignancies

NCT01321346

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +20 more
Locations: Childrens Hospital Los Angeles Los Angeles, California, United States

UCSF School of Medicine San Francisco, California, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

University of Miami Cancer Center Miami, Florida, United States

View all 20 locations

View Trial Details

Completed

Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701)

NCT00034684

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +22 more
Locations: Not specified

View Trial Details

Completed

Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation

NCT00030186

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +3 more
Locations: Not specified

View Trial Details

Completed

Gleevec/Low-Dose Ara-C Study for Elderly Patients With AML and Myelodysplastic Syndromes

NCT00451997

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation

NCT00144703

Conditions: Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Graft vs Host Disease, +23 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Treatment of Imminent Haematological Relapse in Patients With AML and MDS Following Allogeneic Stem Cell Transplantation With 5-azacitidine (Vidaza®)

NCT00422890

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: University hospital Dresden, department of medicine Dresden, Saxony, Germany

View Trial Details

Completed

A Trial Comparing a Prophylactic With a Therapeutic Platelet Transfusion Strategy in Two Groups

NCT00521664

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations: Klinikum Nürnberg Nord; Einheit für Knochenmarktransplantation; 5. Med. Klinik Nuremberg, Germany

View Trial Details

Completed

Safety, Tolerability, PK and Efficacy of AZD1152 in Patients With Relapsed Acute Myeloid Leukemia

NCT00497991

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations: Research Site New York, United States

Research Site Houston, Texas, United States

Research Site Angers, France

Research Site Grenoble, France

View Trial Details